Use of mycophenolate mofetil in patients with transplanted heart and renal insufficiency: the relevance of the pharmacokinetic study.
Arizón del Prado
J M
JM
Heart Transplantation Unit, Department of Anesthesia, Hospital Universitario Reina Sofía, Cordoba, Spain.
Aumente
M D
MD
Lopez Granados
A
A
Siles
J R
JR
Paulovic
D
D
Romo
E
E
Concha
M
M
Vallés
F
F
Casares
J
J
Muñoz
I
I
Segura
C
C
Muñoz
M I
MI
D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000150:complications* / Q000378:metabolism; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009173:Mycophenolic Acid